Skip to content
Open access

Microglia drive demyelination via multiple sclerosis antibodies and BTK signaling

Aug 2026 · bioRxiv · 0 citations · 87 references
Biology

TL;DR

Inhibition of Bruton’s tyrosine kinase (BTK) limited microglial transcriptional changes and prevented myelin loss following microglial envelopment and support BTK inhibition as a therapeutic strategy to prevent demyelination by modulating microglia behavior.

Read PDF

Similar papers

Review Aug 2026

Decoding TREM2: A microglial receptor governing the fate of myelin.

Impaired myelin integrity and defective myelin regeneration represent core pathological features shared by central nervous system (CNS) diseases, such as multiple sclerosis (MS), Alzheimer's disease (AD), ischemic cerebral white matter lesions and spinal cord injury (SCI). Triggering Receptor Expressed on Myeloid Cells...

Ze-Hao Zhang, Wen-Jing Zhang, Long Jin et al. · 0 citations
Review Open access Aug 2026

Crosstalk Between Oligodendrocyte Lineage Cells and CNS‐Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis

Current knowledge of OLC biology in health and disease is synthesized, with emphasis on complex intercellular interactions that determine demyelination, remyelination, and axonal integrity in MS.

Joohyun Park, So Yeong Cheon, F. Guo · 0 citations
Open access Aug 2026

Assessing microglial phagocytosis of apoptotic neurons in vitro: a multimodal approach

Microglia are the resident immune cells of the central nervous system, responsible for defending against infections, responding to tissue damage, and maintaining homeostasis. Dysregulation of their phagocytic activity has been implicated in many neurodegenerative diseases of the brain and the eye, including Alzheimer's...

A. Mukwaya, Zhuoran Yin, Ryan Yarcusko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.